TITLE

Subclinical type 1 diabetes

AUTHOR(S)
Chowdhury, Tahseen A.; Lasker, Shawarma S.
PUB. DATE
April 2002
SOURCE
Journal of the Royal Society of Medicine;Apr2002, Vol. 95 Issue 4, p203
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article describes the case of a 23-year-old woman who consulted her doctor because of sore throat, lethargy and flu-like symptoms and who was diagnosed with subclinical type 1 diabetes after taking an oral glucose tolerance test. She has been taking repaglinide with meals and has good glycemic control. Young persons who are islet cell antibody-positive, have a first-degree kin with type 1 diabetes and have high-risk HLA haplotypes will eventually develop diabetes that requires insulin.
ACCESSION #
23070426

 

Related Articles

  • Demand up for better glucose self-monitoring devices.  // Healthcare Purchasing News;May2003, Vol. 27 Issue 5, p24 

    Reports on an increase in the demand for glucose self-monitoring devices in the U.S. Factors that contribute to the growing incidence of diabetes; Reason behind the adoption of devices; Revenue posted by self-monitoring devices market in 2002.

  • Ten-year follow-up report on Birmingham Diabetes Survey of 1961.  // British Medical Journal;7/3/1976, Vol. 2 Issue 6026, p35 

    Focuses on the effects of glucose tolerance test (GTT) on diabetic patients included in the Birmingham Diabetes Survey of 1961 in England. Reactions of patients belonging to the controlled group; Identification of abnormalities of the GTT diabetes; Diagnosis for development of florid diabetes.

  • oral glucose tolerance test.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1639 

    A definition of the term "oral glucose tolerance test," which refers to a screening test for diabetes mellitus, is presented.

  • Fasting Glucose and Progression of Impaired Glucose Tolerance. Cockram, Clive S.; Chou, Pesus; Chia-Lin Li; Shih-Tzer Tsai // Diabetes Care;Feb99, Vol. 22 Issue 2, p369 

    Comments on a study which examined progression of diabetes from impaired glucose tolerance conducted by researcher Pesus Chou. Methodology; Findings of the study; Response from the author of the study.

  • Pioglitazone for diabetes prevention. Elliott, William T. // Infectious Disease Alert;May2011 Clinical Bri, p1 

    The article reports on the discovery that pioglitazone reduces the risk of diabetes among patients with impaired glucose tolerance in an industry-sponsored study.

  • Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test? Stern, Michael P.; Williams, Ken; Haffner, Steven M. // Annals of Internal Medicine;4/16/2002, Vol. 136 Issue 8, p575 

    Background: The standard method of identifying persons at high risk for type 2 diabetes mellitus involves detection of impaired glucose tolerance, which requires a costly and inconvenient 2-hour oral glucose tolerance test. Because clinical trials have indicated that diabetes is preventable by...

  • The Prevalent Glu23Lys Polymorphism in the Potassium Inward Rectifier 6.2 (KIR6.2) Gene Is Associated With Impaired Glucagon Suppression in Response to Hyperglycemia. Tschritter, Otto; Stumvoll, Michael; Machicao, Fausto; Holzwarth, Martin; Weisser, Melanie; Maerker, Elke; Teigeler, Anna; Haring, Hans; Häring, Hans; Fritsche, Andreas // Diabetes;Sep2002, Vol. 51 Issue 9, p2854 

    Genetic factors play an important role in the pathogenesis of type 2 diabetes. The relevance to type 2 diabetes of the common polymorphism Glu23Lys in the potassium inward rectifier 6.2 (KIR6.2) gene is still controversial. The aim of this study was to assess whether this polymorphism influences...

  • Self testing for diabetes mellitus. Davies, Melanie; Alban-Davies, Huw; Cook, Christopher; Day, John // BMJ: British Medical Journal (International Edition);9/21/91, Vol. 303 Issue 6804, p696 

    Focuses on the self-testing for diabetes mellitus in Great Britain. Risk of macrovascular complications; Initiation of oral glucose tolerance tests; Number of cases identified.

  • Glucose tolerance during long term treatment with a somatostatin analogue. Verschoor, Louis; Lamberts, Steven W.J.; Uitterlinden, Piet; del Pozo, Emilio // British Medical Journal (Clinical Research Edition);11/22/1986, Vol. 293 Issue 6558, p1327 

    Studies the glucose tolerance during long term treatment with a somatostatin analogue. Increase in postprandial glucose concentration; Development of diabetes mellitus; Side effects on glucose tolerance in patients with acromegaly.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics